UK markets open in 5 hours 34 minutes
NIKKEI 225
38,659.25 -44.26 (-0.11%) HANG SENG
18,476.80 0.00 (0.00%) CRUDE OIL
75.69 +0.14 (+0.19%) GOLD FUTURES
2,393.70 +2.80 (+0.12%) DOW
38,886.17 +78.84 (+0.20%) Bitcoin GBP
55,313.50 -246.10 (-0.44%)
BMY Sep 2024 49.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:16AM EDT. Market open.
| Previous close | 0.3300 |
| Open | 0.3200 |
| Bid | 0.3000 |
| Ask | 0.3500 |
| Strike | 49.00 |
| Expiry date | 2024-09-20 |
| Day's range | 0.3200 - 0.3200 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.06k |
Insider MonkeyHere’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
We recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co (NYSE:BMY) ranks 2nd in the list. Click to see the full list of 11 stocks Cramer is bearish on. In this article we will take a deeper look at BMY and find out whether Cramer’s thesis holds any weight. […]
ZacksBristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
- Zacks
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
© 2024 Yahoo. All rights reserved.